When a testosterone schedule sounds simpler than the evidence Weekly subcutaneous testosterone undecanoate should not be treated like an already settled standard of care. Product, route, schedule, and evidence each need their own…
Updated labels change the conversation, not the need for careful screening The headline change sounds reassuring at first glance, but the article makes clear that blood pressure monitoring now deserves more attention, not…
A Label Change Does Not Replace Individual Risk Review Why the 2025 FDA shift changes the conversation around menopausal hormone therapy without removing the need for careful screening How timing, formulation, and route…
When menopause symptoms return after cancer treatment, the path forward needs nuance Older hormone studies still shape today’s caution, even as newer expert consensus pushes for more individualized risk review. Non-hormonal care and…
When Hormone Dosing Needs a Closer Look Helpful context for readers dealing with hot flashes, sleep disruption, mood variability, or dose-sensitive symptom swings. A clearer bridge between today’s lab-based hormone care and the…
Takeaways Bioengineered ovary scaffolds may one day restore hormone function more naturally than conventional HRT. These implants aim to mimic feedback loops and hormone cycles rather than deliver static doses. Clinical use remains…
Takeaways Daxxify offers significantly longer-lasting results (6–9 months) compared to traditional neuromodulators, making it especially appealing for patients with hormonal fluctuations. No peer-reviewed research yet exists linking Daxxify’s use to stabilizing estrogen-influenced dermal changes,…
Takeaways Designer Estrogens 2.0 offer targeted bone and cognitive benefits while minimizing breast and uterine cancer risks. The 2025 UCSF Phase II trial shows improved bone density and memory with no evidence of…
Takeaways Nasal testosterone gel mimics natural hormone rhythms while preserving sperm production. It avoids partner exposure and supports high patient satisfaction through convenience. FDA-approved Natesto offers fertile men a reliable TRT option with…
Takeaways RPN-001 is an oral, fertility-preserving alternative to injectable testosterone that stimulates natural hormone production without suppressing sperm count. Clinical trials show promising improvements in testosterone levels and motile sperm counts, with a…